999-22-4

Usage

Uses

Used in Polyurethane Industry:
N,N''-ethylenebis[N-methylpropane-1,3-diamine] is used as a cross-linking agent for the production of polyurethane foams, elastomers, and coatings. It contributes to the improvement of the material's physical properties by forming robust cross-links, which increase the strength, durability, and resistance to abrasion and chemicals of the final product.
Used in Epoxy Resin Industry:
In the epoxy resin industry, N,N''-ethylenebis[N-methylpropane-1,3-diamine] serves as a curing agent. Its application ensures the hardening and setting of epoxy resins, which is crucial for various applications that require strong and durable adhesives or coatings.
Used in Pharmaceutical and Agrochemical Industries:
N,N''-ethylenebis[N-methylpropane-1,3-diamine] also finds use as a component in certain pharmaceuticals and agrochemicals, where its unique chemical structure may contribute to the development of new drugs or enhance the effectiveness of existing ones.
Safety Precautions:
Due to its potential irritant and sensitizing properties, N,N''-ethylenebis[N-methylpropane-1,3-diamine] should be handled and used with appropriate safety measures to prevent adverse health effects. Proper protective equipment and handling procedures are essential when working with this chemical compound.

Upstream product

• 999-23-5 N,N'-bis-(2-cyanoethyl)-N,N'-dimethyl-ethylenediamine 
• 57356-17-9 N,N'-bis(β-carbamoylethyl)-N,N'-dimethylethylenediamine 

Downstream Products

• 1756-20-3 N,N'-Dimethyl-N.N'-bis-<3-(3.4.5-trimethoxy-benzoyamino)-propyl>-aethylendiamin 

Relevant academic research and scientific papers

Copper(II) complexes of diamino diamide and diamino diamine in aqueous solution

In order to study the difference on the equilibrium, spectral properties of copper(II) complexes of diamino diamide and diamino diamine, new tetradentate ligands, 4,7-dimethyl-4,7-diazadecanediamide (4,7-N,N′ -Me2-L-2,2,2) and 1,10-diamino-4,7-

Prodrug derivatives of enzyme inhibitors having hydroxyl groups, a process for preparing them, and their use

The invention concerns prodrugs of enzyme inhibitors in which at least one OH-- group in the enzyme inhibitor has been converted into a derivative grouping of the formula III, IV or V: STR1 in which the groups R11 to R25 and s,l, m, o, q, and r are as defined in the description. Such prodrugs exhibit an improved solubility in water and improved pharmaco-kinetic characteristics.